Position in ALKS
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,309
+$425 QoQ
Shares Held
25
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#389
of 421 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DiNuzzo Private Wealth, Inc. holds $15,842 across 10 Drug Manufacturers - Specialty & Generic names. ALKS ranks #5 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
12 | $6,501 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
94 | $2,313 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
12 | $2,022 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
48 | $1,626 | |
| 5 | ALKS |
Alkermes plc.
This page
|
25 | $1,309 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
5 | $554 | |
| 7 | ZTS |
Zoetis Inc.
|
7 | $503 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
26 | $450 |
All Filings in ALKS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,309 | 25 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $884 | 25 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $727 | 26 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $780 | 26 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $600 | 21 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $594 | 18 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $517 | 18 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $419 | 15 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $361 | 15 | Shares | Sole | 2024-07-30 | |
| 2023-12-31 | $27 | 1 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||